학술논문

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
Document Type
article
Author
Klonoff, David CWang, JingRodbard, DavidKohn, Michael ALi, ChengdongLiepmann, DorianKerr, DavidAhn, DavidPeters, Anne LUmpierrez, Guillermo ESeley, Jane JeffrieXu, Nicole YNguyen, Kevin TSimonson, GreggAgus, Michael SDAl-Sofiani, Mohammed EArmaiz-Pena, GustavoBailey, Timothy SBasu, AnandaBattelino, TadejBekele, Sewagegn YeshiwasBenhamou, Pierre-YvesBequette, B WayneBlevins, ThomasBreton, Marc DCastle, Jessica RChase, James GeoffreyChen, Kong YChoudhary, PratikClements, Mark AClose, Kelly LCook, Curtiss BDanne, ThomasDoyle, Francis JDrincic, AngelaDungan, Kathleen MEdelman, Steven VEjskjaer, NielsEspinoza, Juan CFleming, G AlexanderForlenza, Gregory PFreckmann, GuidoGalindo, Rodolfo JGomez, Ana MariaGutow, Hanna AHeinemann, LutzHirsch, Irl BHoang, Thanh DHovorka, RomanJendle, Johan HJi, LinongJoshi, Shashank RJoubert, MichaelKoliwad, Suneil KLal, Rayhan ALansang, M CeciliaLee, Wei-AnLeelarathna, LalanthaLeiter, Lawrence ALind, MarcusLitchman, Michelle LMader, Julia KMahoney, Katherine MMankovsky, BorisMasharani, UmeshMathioudakis, Nestoras NMayorov, AlexanderMessler, JordanMiller, Joshua DMohan, ViswanathanNichols, James HNørgaard, KirstenO’Neal, David NPasquel, Francisco JPhilis-Tsimikas, AthenaPieber, ThomasPhillip, MoshePolonsky, William HPop-Busui, RodicaRayman, GerryRhee, Eun-JungRussell, Steven JShah, Viral NSherr, Jennifer LSode, KojiSpanakis, Elias KWake, Deborah JWaki, KayoWallia, AmishaWeinberg, Melissa EWolpert, HowardWright, Eugene EZilbermint, MihailKovatchev, Boris
Source
Journal of Diabetes Science and Technology. 17(5)
Subject
Biomedical and Clinical Sciences
Nutrition and Dietetics
Diabetes
Adult
Humans
Blood Glucose
Blood Glucose Self-Monitoring
Hypoglycemia
Hyperglycemia
Glucose
ambulatory glucose profile
composite metric
continuous glucose monitor
diabetes
glycemia risk index
hyperglycemia
hypoglycemia
time in range
Nutrition and dietetics
Language
Abstract
BackgroundA composite metric for the quality of glycemia from continuous glucose monitor (CGM) tracings could be useful for assisting with basic clinical interpretation of CGM data.MethodsWe assembled a data set of 14-day CGM tracings from 225 insulin-treated adults with diabetes. Using a balanced incomplete block design, 330 clinicians who were highly experienced with CGM analysis and interpretation ranked the CGM tracings from best to worst quality of glycemia. We used principal component analysis and multiple regressions to develop a model to predict the clinician ranking based on seven standard metrics in an Ambulatory Glucose Profile: very low-glucose and low-glucose hypoglycemia; very high-glucose and high-glucose hyperglycemia; time in range; mean glucose; and coefficient of variation.ResultsThe analysis showed that clinician rankings depend on two components, one related to hypoglycemia that gives more weight to very low-glucose than to low-glucose and the other related to hyperglycemia that likewise gives greater weight to very high-glucose than to high-glucose. These two components should be calculated and displayed separately, but they can also be combined into a single Glycemia Risk Index (GRI) that corresponds closely to the clinician rankings of the overall quality of glycemia (r = 0.95). The GRI can be displayed graphically on a GRI Grid with the hypoglycemia component on the horizontal axis and the hyperglycemia component on the vertical axis. Diagonal lines divide the graph into five zones (quintiles) corresponding to the best (0th to 20th percentile) to worst (81st to 100th percentile) overall quality of glycemia. The GRI Grid enables users to track sequential changes within an individual over time and compare groups of individuals.ConclusionThe GRI is a single-number summary of the quality of glycemia. Its hypoglycemia and hyperglycemia components provide actionable scores and a graphical display (the GRI Grid) that can be used by clinicians and researchers to determine the glycemic effects of prescribed and investigational treatments.